Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cox

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
JAMA|December 7, 2007
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trialGregg W Stone, James H Ware, Michel E Bertrand, et al.
American Heart Journal|March 30, 2006
Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trialAmir Halkin, A Zaki Masud, Campbell Rogers, et al.
Circulation. Cardiovascular Interventions|December 9, 2015
Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES StudyTomotaka Dohi, Akiko Maehara, Bernhard Witzenbichler, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention PopulationSorin J Brener, Ajay J Kirtane, Michael J Rinaldi, et al.
Circulation|April 7, 2005
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialAlexandra J Lansky, Cody Pietras, Ricardo A Costa, et al.
Journal of Thrombosis and Thrombolysis|October 19, 2010
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trialAdriano Caixeta, Gregg W Stone, Roxana Mehran, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
Circulation. Cardiovascular Interventions|October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES StudyGiora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
JAMA|December 7, 2007
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trialGregg W Stone, James H Ware, Michel E Bertrand, et al.
American Heart Journal|March 30, 2006
Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trialAmir Halkin, A Zaki Masud, Campbell Rogers, et al.
Circulation. Cardiovascular Interventions|December 9, 2015
Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES StudyTomotaka Dohi, Akiko Maehara, Bernhard Witzenbichler, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention PopulationSorin J Brener, Ajay J Kirtane, Michael J Rinaldi, et al.
Circulation|April 7, 2005
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialAlexandra J Lansky, Cody Pietras, Ricardo A Costa, et al.
Journal of Thrombosis and Thrombolysis|October 19, 2010
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trialAdriano Caixeta, Gregg W Stone, Roxana Mehran, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
Circulation. Cardiovascular Interventions|October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES StudyGiora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.
Pageof 17